Skip to content
Home/Companies/Industrials/Bormioli Pharma

Bormioli Pharma

Industrials·Italy·Exited 2024·Held 7yr
Entry
2017
Hold
7yr
Exit
2024

Who owns Bormioli Pharma?

Bormioli Pharma was owned by Triton Partners through Triton Fund IV (2013 vintage) from 2017 to 2024, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Triton Partners
Investor
Triton Partners
Triton Fund IV · 2013 · Buyout

Key facts

HQSweden
SectorIndustrials
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2024

More from Triton Fund IV

Other portfolio companies in the same fund.

Cobex
Exited 2019
IndustrialsGermany· 2017
to
Eleda Group
Eleda Group
Exited 2020
Business ServicesSweden· 2017
to
Glamox
Active
IndustrialsNorway· 2017
Ramudden
Active
Business ServicesSweden· 2017
Ramudden Global
Ramudden Global
Exited 2026
Business ServicesSweden· 2017
to
DeepOcean
DeepOcean
Exited 2025
EnergyNorway· 2016
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Bormioli Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Bormioli Pharma?

0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Bormioli Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue